Navigation Links
Vascular Insights Receives FDA Clearance for Infusion Catheter
Date:5/6/2008

MADISON, Conn., May 6 /PRNewswire/ -- Vascular Insights LLC announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ClariVein(TM) infusion catheter for infusion of physician-specified agents in the peripheral vasculature.

ClariVein(TM) is a percutaneous, 2 2/3 Fr (0.035") catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.

"We are delighted with this development," said John P. Marano, co-founder, president, and chief executive office of Vascular Insights. "The FDA decision clears the way for the commercialization of ClariVein(TM) and promises to dramatically shorten our time-to-market."

Vascular Insights LLC (http://vascularinsights.com) of Madison, Conn., engages in the design, development, manufacture, and marketing of medical devices for the minimally invasive treatment of peripheral vascular disease. The company was co-founded by John P. Marano and Dr. Michael Tal, based on Dr. Tal's insights into interventional procedures. Dr. Tal is chief medical advisor to the company and associate professor of radiology at Yale University School of Medicine.

Contact:

Bill Kelly

HarveyMalis Communications LLC

bill@harveymalis.com

203-375-2696


'/>"/>
SOURCE Vascular Insights LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
2. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
3. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
4. LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
5. Spirit of the Heart: Preventing Cardiovascular Disease: A Community Call to Action
6. MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery
7. LeMaitre Vascular Announces Changes to Its Executive Management Team
8. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
9. Sexual dissatisfaction in postmenopausal women not linked to cardiovascular disease
10. Mary Cheney Joins the Cheney Cardiovascular Institute Board of Directors
11. MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2017)... ... , ... AgileMinder develops innovative products and services that bring "Care, Joy and ... Apple as a fun, free emoji sticker pack for iMessage. Use the stickers in ... coded values on The Emoji Scale. , On Apple: "The Emoji Scale by ...
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: ... hotel on March 3-4, 2017. This Congress is expertly designed to meet the ... of patients with lung cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of ...
(Date:1/13/2017)... ... 2017 , ... With the increasing public preference for chemical-free ... organic alternatives for customers who have grown more conscious about maintaining their health ... activated charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained their company’s ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive teeth ... pain whenever they brush their teeth. Sadly, most dental hygiene products in the market ... and teeth. For these people, continuing their daily oral care routine to keep their ...
(Date:1/13/2017)... ... January 13, 2017 , ... ... the Finnleo factory in Cokato, MN, with the official send-off from Orchestra Hall ... Maestro Osmo Vanska , Minnesota Orchestra’s Music Director, leading the official launch of ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... 2017 Eli Lilly and Company (NYSE: ... INCY ) announced today that the U.S. Food and ... the new drug application (NDA) for investigational baricitinib, a ... severe rheumatoid arthritis (RA). The NDA for baricitinib was ... The FDA extended the action date to allow time ...
(Date:1/13/2017)... -- Wichita Laser Clinic at Healthy Life ... Wichita, Kansas featuring the Astanza Revolution ... rejuvenation, getting rid of unwanted tattoos, killing toenail fungus, ... "Since being in the aesthetics industry, I have ... for laser tattoo removal and other popular cosmetic ...
(Date:1/13/2017)... , Jan. 12, 2017   JDRF ... diabetes (T1D) research, is pleased to announce that ... the Centers for Medicare & Medicaid Services (CMS) ... by the FDA for use in making diabetes ... step toward making them eligible for coverage under ...
Breaking Medicine Technology: